Key result
The ABSORB bioresorbable vascular scaffold requires careful attention to procedural details and implantation technique to achieve optimal clinical outcomes.
This review highlights the current evidence and guidelines for the ABSORB bioresorbable vascular scaffold, emphasizing the need for meticulous implantation technique to achieve optimal outcomes despite limited long-term safety data.
The advent of fully bioresorbable stent technology and specifically the ABSORB™, a bioresorbable vascular scaffold (BVS) stent, is heralded as breakthrough technology in the current era of percutaneous coronary interventions. This article reviews the current understanding of this technology along with the clinical evidence from trials and registries of ABSORB BVS that included patients with both simple as well as more complex "real-world" coronary lesions. In addition, considering the current limitations of this device-mostly associated with the mechanical properties of the polymeric scaffold structure-a review of guidelines on successful implantation of the ABSORB BVS is presented. Although expert feedback suggests extensive use of this device in routine clinical practice outside the United States despite a paucity of data on long-term safety in this setting, attention to procedural details and implantation technique is obligatory to achieve optimal clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Rizik et al. (2015) conducted a review in Coronary lesions. ABSORB bioresorbable vascular scaffold (BVS) was evaluated. The ABSORB bioresorbable vascular scaffold requires careful attention to procedural details and implantation technique to achieve optimal clinical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: